<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02763150</url>
  </required_header>
  <id_info>
    <org_study_id>CP-GDPP-trial</org_study_id>
    <nct_id>NCT02763150</nct_id>
  </id_info>
  <brief_title>Pre-pregnancy Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes in Overweight and Obese Women</brief_title>
  <official_title>Gestational Diabetes Prevention Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>California Polytechnic State University-San Luis Obispo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>California Polytechnic State University-San Luis Obispo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall purpose of this study is to determine the efficacy of a pre-pregnancy lifestyle
      intervention to reduce the recurrence of gestational diabetes mellitus in multiethnic women
      with overweight or obesity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Gestational Diabetes Mellitus</measure>
    <time_frame>26 weeks gestation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in maternal levels of fasting glucose</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in maternal levels of fasting insulin</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in maternal levels of systolic and diastolic blood pressure</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in maternal levels of C-reactive protein</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of preeclampsia</measure>
    <time_frame>Delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of cesarean delivery</measure>
    <time_frame>Delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight changes</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily caloric intake</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minutes per week of moderate physical activity</measure>
    <time_frame>study entry, 16 weeks, 26 weeks gestation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Gestational Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group will receive a comprehensive, multicomponent weight loss intervention targeting diet, physical activity, and behavioral strategies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Promotion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Health promotion group will receive education on healthy eating and activity before pregnancy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle intervention</intervention_name>
    <description>Intervention group will receive comprehensive behavioral weight loss program.</description>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Health Promotion</intervention_name>
    <description>The health promotion group will receive education on healthy eating and activity</description>
    <arm_group_label>Health Promotion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prior diagnosis of gestational diabetes.

          -  BMI &gt; 25 kg/m2

          -  Planning to have a baby in the next 1-3 years

          -  English or Spanish speaking

        Exclusion Criteria:

          -  Age less than 18 years

          -  Women with Type 2 or Type 1 diabetes

          -  Current pregnancy

          -  Relocating in the next 2 years

          -  Medications that affect weight/diabetes

          -  Serious current physical disease

          -  History of eating disorders

          -  History of bariatric surgery

          -  Current problems with drug abuse

          -  Current treatment of a serious psychological disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suzanne Phelan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>California Polytechnic State University-San Luis Obispo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Casey Heaney, MS</last_name>
    <phone>805 756 5365</phone>
    <email>heaney@calpoly.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angelica McHugh, MS</last_name>
    <phone>401 793 8978</phone>
    <email>amchugh1@lifespan.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>California Polytechnic State University</name>
      <address>
        <city>San Luis Obispo</city>
        <state>California</state>
        <zip>93401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey Heaney, B.S.</last_name>
      <phone>805-756-5365</phone>
      <email>heaney@calpoly.edu</email>
    </contact>
    <investigator>
      <last_name>Suzanne Phelan, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelica McHugh, MS</last_name>
      <phone>401-793-8978</phone>
      <email>amchugh1@lifespan.org</email>
    </contact>
    <investigator>
      <last_name>Rena R Wing, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>California Polytechnic State University-San Luis Obispo</investigator_affiliation>
    <investigator_full_name>Suzanne Phelan</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Gestational Diabetes Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>A de-identified dataset will be made available to outside investigators after the primary and secondary analyses are completed and in accordance with local institutional review board and NIH policies.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

